Cart summary

You have no items in your shopping cart.

AS1810722

SKU: orb1217490

Description

AS1810722 is an orally active and potent STAT6 inhibitor(IC50 :1.9 nM). AS1810722 shows a good profile of CYP3A4 inhibition. AS1810722, a derivative of fused bicyclic pyrimidine, has the potential for allergic diseases such as asthma and atopic diseases research.

Images & Validation

Key Properties

CAS Number909561-15-5
MW477.5
Purity>98% (HPLC)
FormulaC25H25F2N7O
TargetCYP3A4|STAT6

Storage & Handling

StorageStorage temperature: -20°C. Stability: ≥ 2 years
DisclaimerFor research use only

Similar Products

  • AS1810722 [orb1298418]

    99.13%

    909561-15-5

    477.51

    C25H25F2N7O

    10 mg, 5 mg, 1 ml x 10 mM (in DMSO), 1 mg, 25 mg, 50 mg
Quality Guarantee

Quality Guarantee

Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Documents Download

Datasheet
Product Information
Download

Request a Document

Protocol Information

AS1810722 (orb1217490)

  • Star
  • Star
  • Star
  • Star
  • Star
  • 0.0
Based on 0 reviews

Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.

Login to Submit a Review

No reviews yet

Step 1: Enter information below

(Recommended: An additional animal making an allowance for loss during the experiment)

Step 2: Enter the in vivo formulation

(This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO +
%+
% Tween 80 +
%

Available Sizes

Select a size below

100 mg
200 mg
500 mg
5 mg
¥ 4,550.00
10 mg
¥ 7,020.00
25 mg
¥ 11,440.00
50 mg
¥ 16,120.00